BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Tusamitamab sonditecan readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Tusamitamab sonditecan\, from ClinicalTri
 als.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06131840-2678@assetmemo.bio
DTSTAMP:20261121T005725Z
DTSTART;VALUE=DATE:20290912
DTEND;VALUE=DATE:20290913
SUMMARY:Tusamitamab sonditecan: Phase 1 readout est. (NCT06131840)
DESCRIPTION:Tusamitamab sonditecan\, phase 1\, Non-Small Cell Lung Cancer.\
 nStudy: A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors\nEsti
 mated primary completion: 12 September 2029. This is a ClinicalTrials.gov 
 estimate\, not a confirmed readout date\, and it can move.\nDrug page: htt
 ps://assetmemo.bio/drug/tusamitamab-sonditecan#upcoming-events\nRegistry r
 ecord: https://clinicaltrials.gov/study/NCT06131840
URL:https://assetmemo.bio/drug/tusamitamab-sonditecan#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
